Skip to main content

HEOR Research Reviews

Featured Article
No biologic strategies in treatment guidelines for ankylosing spondylitis were cost-effective at a willingness-to-pay threshold of $100,000 per quality-adjusted life-year.
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other…

Literature Review

Currently, chimeric antigen receptor T-cell (CAR-T) therapies are regulated as drugs—often leading to higher prices and barriers to access for patients, as well as financial strains for hospitals…

Acute myeloid leukemia (AML) is an aggressive type of blood cancer in which the bone marrow makes abnormal myeloblasts, or immature white blood cells, resulting in low healthy white cell count.…

Rheumatoid arthritis (RA) continues to affect as many as 1.5 million adults in the United States.1 Women are 2 to 3 times as likely to be affected as men.2

The burden of this disease is…

Neuroendocrine tumors (NETs) are thought to arise from cells throughout the diffuse endocrine system.1,2 According to a report published in JAMA Oncology, the incidence and prevalence of…

Back to Top